Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery.
about
Silica Vesicle Nanovaccine Formulations Stimulate Long-Term Immune Responses to the Bovine Viral Diarrhoea Virus E2 ProteinExpression of Histophilus somni IbpA DR2 protective antigen in the diatom Thalassiosira pseudonana.Size and surface modification of amorphous silica particles determine their effects on the activity of human CYP3A4 in vitro.Immunisation of Sheep with Bovine Viral Diarrhoea Virus, E2 Protein Using a Freeze-Dried Hollow Silica Mesoporous Nanoparticle Formulation.Potential of nanoparticles for allergen-specific immunotherapy - use of silica nanoparticles as vaccination platform.Cholesteryl Pullulan Encapsulated TNF-α Nanoparticles Are an Effective Mucosal Vaccine Adjuvant against Influenza VirusSelf-assembled PEG-b-PDPA-b-PGEM copolymer nanoparticles as protein antigen delivery vehicles to dendritic cells: preparation, characterization and cellular uptakeAssessment of the adjuvant activity of mesoporous silica nanoparticles in recombinant Mycoplasma hyopneumoniae antigen vaccines.The practicality of mesoporous silica nanoparticles as drug delivery devices and progress toward this goal.Small Wonders-The Use of Nanoparticles for Delivering Antigen.Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines.Biomimetic nanoassembly for targeted antigen delivery and enhanced Th1-type immune response.Gold nanocluster-based vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides.Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy?Immune response to functionalized mesoporous silica nanoparticles for targeted drug delivery.Advances in Anticancer Protein Delivery Using Micro-/ Nanoparticles.An overview on the role of silica-based materials in vaccine development.Mesoporous Silica Nanoparticle-Coated Microneedle Arrays for Intradermal Antigen DeliveryIn vivo delivery of bovine viral diahorrea virus, E2 protein using hollow mesoporous silica nanoparticles.Microbially synthesized modular virus-like particles and capsomeres displaying group A streptococcus hypervariable antigenic determinants.Evidence of size-dependent effect of silica micro- and nano-particles on basal and specialized monocyte functions.Mesoporous Silica and Organosilica Nanoparticles: Physical Chemistry, Biosafety, Delivery Strategies, and Biomedical Applications.Strong in vivo antitumor responses induced by an antigen immobilized in nanogels via reducible bonds.Mesoporous ZnO nanocapsules for the induction of enhanced antigen-specific immunological responses.Facile synthesis of mesoporous silica and titania supraparticles by a meniscus templating route on a superhydrophobic surface and their application to adsorbents.Nanoparticle Vaccines Adopting Virus-like Features for Enhanced Immune PotentiationProgrammable drug release using bioresponsive mesoporous silica nanoparticles for site-specific oral drug deliveryNoncovalent functionalization of mesoporous silica nanoparticles with amphiphilic peptidesCoated and Hollow Microneedle-Mediated Intradermal Immunization in Mice with Diphtheria Toxoid Loaded Mesoporous Silica Nanoparticles
P2860
Q27340109-06A5DF0D-B1CF-4E77-980D-BA4E4E419325Q33841510-3393C153-AC31-446D-828F-35B901DB89EDQ34702892-94F7FFF9-C520-4A2D-A2D9-ED22E63C6288Q35831775-8342EE61-C19A-4446-B4B7-F970484F0170Q36056484-C55DCA8E-2DBA-4A7F-AB56-F935FA78873EQ36059495-5E7B1D10-4310-44E7-8446-2593C03C86B6Q37611358-6AD3B073-8237-4BC2-9808-DD5B54ABCEB1Q37624395-D67DC1A7-C71C-4017-9C97-32CEC22EF092Q38215663-66DF3A5E-E291-4A45-AAE6-1CE26FE27734Q38583148-AFAFC082-D63A-4B4C-9602-3472477475FFQ38676164-10D930A9-DF4B-417B-877A-AC4F5FEE1365Q38834398-0289C570-5FE4-4D17-9B42-0D7CB2C810D0Q38858337-F7BA37B3-08FE-4CB4-977F-66817B061606Q38912004-D691B980-6D7D-4BBE-9F7A-3E6C39F98953Q38932756-74CDB925-52C4-4092-B6C7-4104F97244D8Q39092873-550B8720-05DB-4923-B9DD-6C81905A5D2AQ39781727-1CEB64B3-41B6-4972-AB0D-DE65D2683EF4Q40956743-FAFDA493-02FA-4D77-BF5B-B5AB14570EEFQ42219732-CE900996-ADCF-4753-B35A-08C94CC61541Q42249041-43F1B5E5-8FA8-4EE1-A91E-62B250670E80Q47177066-CF90699C-1966-426F-A5D4-5919DF5882C5Q47295411-51FE5ACC-77B4-4F95-9701-D36A4C9B08FBQ48974238-9B24B32C-8B52-4F01-99D5-1D21F8A926F0Q49946285-21BCD3F3-DFC3-404C-B91A-FFAC951B1435Q50226809-B994D4A7-FE58-411F-BA95-9B88D0D9C547Q56993652-048EAB5D-37BC-47B4-BB4D-7DC2C9E2EEE0Q57365208-56739E63-F003-450C-BD36-F0F4A5F01C1EQ58676878-82AA449C-C18B-41EB-9900-0061C6837DA2Q58785973-B3F858F0-220A-4DE0-8625-06834348429C
P2860
Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery.
@en
type
label
Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery.
@en
prefLabel
Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery.
@en
P2093
P2860
P50
P356
P1433
P1476
Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery
@en
P2093
Antonino S Cavallaro
Donna Mahony
Neena Mitter
P2860
P304
P356
10.1039/C3NR00357D
P407
P577
2013-06-01T00:00:00Z